Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
Portfolio Pulse from Benzinga Insights
In the last three months, 21 analysts have published ratings on Boston Scientific (NYSE:BSX), with a majority being bullish. The average 12-month price target has increased by 9.97% to $84.62. Analysts have raised their ratings and price targets, reflecting positive sentiment towards the company's financial performance and market position.
July 15, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has received predominantly bullish ratings from analysts over the past three months, with the average 12-month price target increasing by 9.97% to $84.62. This reflects strong market confidence in the company's financial performance and market position.
The majority of analysts have given bullish ratings, and several have raised their price targets, indicating strong confidence in Boston Scientific's future performance. The increase in the average price target by 9.97% further supports this positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100